Héma-Québec studies

SEROPREVALENCE STUDIES

Studies conducted by Héma-Québec in collaboration with the Institut national de santé publique (INSPQ), and in partnership with the COVID-19 Immunity Task Force (CITF), aim to measure the progression of immunity in the population.

CLINICAL STUDY ON CONVALESCENT PLASMA

Héma-Québec was involved in a national clinical trial project, with the objective of developing a passive immunization program for treating people with COVID-19.

PLASMA DONOR BIOBANK

The biobank aims to measure the impact of vaccination, or infection, on the immune response.

This content is not displayed because personalization cookies are disabled for this site. For this reason, your browsing experience is not optimal.
Personalize cookies